iShares 10 20 Year Treasury Bond ETF vs Zoetis Inc — how do they compare? iShares 10 20 Year Treasury Bond ETF trades at $96.05, while Zoetis Inc trades at $73.65 (market cap $30.40B). The key difference: Zoetis Inc pays a 2.88% dividend while iShares 10 20 Year Treasury Bond ETF pays none. Which is the better fit depends on your goals.
| TLH | ZTS | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $105.36 | $150.61 |
52-Week Low | $96.08 | $71.91 |
Market Cap | — | $30.40B |
Enterprise Value | — | $37.96B |
Dividend Yield | — | 2.88% |
Signals from Pluang's Aura AI — not financial advice
TLH trades at $96.52, down 0.09% on the day, with a bearish technical signal from moving averages but a neutral reading from oscillators. Recent corporate actions include dividend payments scheduled for 2026. Key support and resistance levels are tightly clustered around $96-$97. Financial ratios such as P/E, P/S, and ROE are not provided in the current data snapshot.
The outlook for TLH is clouded by the lack of recent fundamental data, making valuation difficult. Investment opportunity hinges on future earnings clarity and dividend sustainability. Risks include market volatility, macroeconomic pressures from rising bond yields and oil prices, and potential impacts from geopolitical tensions on broader equity sentiment.
Zoetis (ZTS) trades at $73.60, down 2.92% amid bearish technical signals and mixed earnings. The stock faces pressure from weakening U.S. companion animal sales and competitive headwinds, though profitability remains strong with 71.67% gross margins and 27.69% net income margin. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a guidance cut. Analyst consensus is divided with 45% Buy ratings and a $93.40 price target, suggesting 27% upside from current levels.
The outlook balances valuation appeal (P/E of 12) against near-term operational challenges. Investment opportunity lies in market dominance and robust cash flow generation, while risks include sustained pet health demand softness and competitive pricing pressure. The stock trades near support at $73, with institutional sentiment mixed amid recent portfolio adjustments.
Trailing returns across standard periods
Latest headlines on both assets
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →